Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Sturman Industries (United States) | Researchclopedia

Back to institutions

Sturman Industries (United States)

Woodland Park, Coloradocompany

36

Works

662

Citations

16

h-index

Top Research Topics

Advanced Combustion Engine Technologies Real-time simulation and control systems Amyloidosis: Diagnosis, Treatment, Outcomes

Top Researchers

Michael Kasper Nanyang Technological University

353 works14,434 citationsh-index: 59

Recent Research

From Subordination to Empowerment: The Journey of Yi Women in Daliangshan

20250 citations

Hydraulic and Pneumatic Systems

Vehicle emissions and performance

Prostate Cancer Treatment and Research

Neuroendocrine Tumor Research Advances

Mast cells and histamine

Textile materials and evaluations

Polyamine Metabolism and Applications

Amino Acid Enzymes and Metabolism

Engineering Applied Research

Christopher W. Turner Auburn University

169 works7,362 citationsh-index: 44

Richard J. Ablin Fujita Health University

299 works3,253 citationsh-index: 26

Bruce Johnson University of Saskatchewan

100 works2,416 citationsh-index: 25

Thomas A. Reichert Forest Research Institute

36 works2,091 citationsh-index: 13

Teresa Rodrigues Epilepsy Research UK

140 works2,065 citationsh-index: 26

Decoding Pictorial Collections Using Faces

Doug Peterson,Hannah Storch

20240 citations

Updated Organ Response Results of an Open-Label Study to Evaluate the Safety and Tolerability of Cael-101 in Patients with AL Amyloidosis Receiving Anti-Plasma Cell Therapy

Jason Valent,John Silowsky,et al.

20212 citations

Safety and Tolerability of Cael-101 in Combination with Anti-Plasma Cell Dyscrasia Therapy in Patients with AL Amyloidosis: 1-Year Results from an Open-Label Phase 2 Trial

Jason Valent,Jeffrey A. Zonder,et al.

20212 citations

Cardiac Amyloid Reaching for Extended Survival (CARES): Study Design of Two Placebo-Controlled, Double-Blind, Randomized, International Phase 3 Trials Assessing Cael-101 in Patients with Mayo Stage Iiia or Stage IIIb AL Amyloidosis

Ashutosh Wechalekar,John Silowsky,et al.

20218 citations

Cael-101 Is Well-Tolerated in AL Amyloidosis Patients Receiving Concomitant Cyclophosphamide-Bortezomib-Dexamethasone (CyborD): A Phase 2 Dose-Finding Study (NCT04304144)

Jason Valent,John Silowsky,et al.

202013 citations